.jpeg "Health Ministry Mandates Blue Strip on All Antimicrobial Drugs")
Union Health Ministry drafts rules mandating blue strip on antimicrobial drugs to curb AMR. Public comments invited; aligns with PM Modi’s antibiotic safety emphasis.
Panchkula-based Venus Remedies has received its second PLI incentive payout for FY25, taking total disbursements to 75%. The release follows the company meeting investment, production, and sales targets under the scheme.
Zydus Lifesciences said its Ankleshwar manufacturing facility received three observations from the USFDA after a recent inspection, adding that none of the findings were linked to data integrity issues.
Naprod Life Sciences has secured an ANVISA GMP renewal for its Tarapur manufacturing facility, reinforcing its compliance with Brazil’s regulatory standards and supporting continued exports of oncology and specialty pharmaceutical products.
Akums Drugs secures EU GMP renewal for Plant 1 and first-time approval for Plant 2 in Haridwar, boosting its global CDMO presence in regulated pharma markets.
Sanofi’s amlitelimab, a promising treatment for moderate-to-severe atopic dermatitis (AD), has shown robust results in two global Phase 3 studies. The findings, along with a favorable safety profile, highlight its potential to improve patients’ quali
Bayer and Vanderbilt University Medical Center (VUMC) have entered a five-year collaboration to accelerate the development of new therapies for cardiovascular and kidney diseases, combining expertise in drug discovery and clinical research.
Corona Remedies Limited has secured the Eurasian Economic Union – Good Manufacturing Practices (EAEU–GMP) certification, marking a significant milestone in its global expansion. Announced on January 22, 2026, this certification allows the compa...
Max Institute of Laparoscopic Surgery, Robotic Surgery, Bariatric Surgery & GI Surgery has entered into a strategic Memorandum of Understanding (MoU) with Intuitive Surgical to accelerate the adoption of robotic-assisted surgery in India. The part...
Sun Pharmaceutical Industries has received DCGI approval for Noveltreat, a generic semaglutide injection designed to help with weight management. The treatment offers a cost-effective solution to combat obesity and related conditions.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")